What Recursion does
Recursion is a clinical-stage biotechnology company applying AI and machine learning to drug discovery and development. It aims to industrialize the discovery process and reduce the high failure rate of traditional drug development by combining large-scale biological experimentation with computational models.
Key capabilities
The company's Recursion Operating System integrates one of the largest proprietary biological datasets, spanning phenomics, transcriptomics, and patient data, with an automated wet lab that uses robotics and computer vision to capture millions of cell experiments. Machine learning models support target identification and molecular design, running on BioHive, a supercomputer built with NVIDIA. The core approach trains AI on cell images to map biological relationships across a vast search space.
Who it's for
Recursion works with pharmaceutical partners on collaborative drug discovery and advances its own pipeline in areas such as oncology, including solid tumors and B-cell malignancies, and rare diseases. Candidates span preclinical through early clinical trials. The company positions its platform as delivering improvements in speed, efficiency, and cost from hit identification through IND-enabling studies.